Chao Lin China: Proposed Breaking Drug Patents Import Barriers
Beijing on March 10 (Xinhua deep steel, Yue Deliang) this year’s government work report, “to control medical expenses” as the advance
Medicine Health care reform and an important part of the development is proposed, and requested that 60% of the government’s implementation of primary health care and health institutions
Essential drugs system . “AIDS, hepatitis B, hepatitis C and leukemia, the four major illness, most patients in the use of foreign drugs, consumption of national wealth is a huge number.” NPC Furun Holdings Chairman Chao Lin China stunned the world.
According to the China Foundation for Hepatitis Prevention and Control provides statistics, there are 120 million hepatitis B virus infection, of which 600 million people need antiretroviral treatment, including 20 million people need to use
GlaxoSmithKline Company production of “lamivudine” (100mg), close to 5,000 yuan per person per year expenditures, total national hepatitis B patient needs a drug expenditures for the 10 million. In two sessions, many delegates believed that it should increase the availability of essential medicines for major diseases, especially those of some
Import Drugs, should be flexibility in the use of legal and trade instruments as a solution, “your doctor” an important step.
Reporter learned that, due to the treatment of these diseases
Drugs Enjoy franchise in the domestic manufacturers, domestic generic pharmaceutical companies can not compete with drug production and drive down prices, high drug prices ultimately borne by patients and the state treasury. Threat of high prices of patented medicines under a variety of patients, its annual consumption of the cost of patented medicines in the purchase of up to several hundred billion dollars. Rely solely on patent medicines into the
Health Insurance Areas can not fundamentally solve the problem, but would create a major new national economic burden.
Chao Lin China said, according to the World Trade Organization, “Agreement on Trade-Related Intellectual Property Rights” and the “Doha Declaration”, a country to address its public health problem, you can use the “flexibility clause”, by issuing a license, and so on, and reasonable to break the patent medicine patent monopoly, access to affordable medication.
“National treatment should be timely start of key drug patent compulsory licensing procedures. Correctly handle the relationship between innovation and imitation, to grasp the initiative in drug supply.” Zhao Lin said in the state can improve the organization and leadership to guide and mobilize the masses, listen to the voice patient, collaborative working together to promote the international trade related to international law and multilateral game.
On behalf of members of the view that China is the world’s largest
API
Producer and exporter, with production of finished drugs and has the full capacity, China’s mandatory generic drugs must be able to greatly reduce the price of drugs, which not only greatly improve our ability to supply drugs, more for other developing countries, especially African countries to improve drug accessibility to contribute.
I am China Manufacturers writer, reports some information about variable data printers , callaway hyper x.
Processing your request, Please wait....
